These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9989741)

  • 21. Interferon beta treatment for multiple sclerosis.
    Johnson KP; Panitch HS
    Lancet; 1999 Feb; 353(9151):494; author reply 497-8. PubMed ID: 9989738
    [No Abstract]   [Full Text] [Related]  

  • 22. Interferon beta in multiple sclerosis. Interferon beta reduces overall relapse rate by one third.
    Napier JC
    BMJ; 1997 Feb; 314(7080):601. PubMed ID: 9055729
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple sclerosis: early management.
    Zajicek J
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):137-40. PubMed ID: 9166373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interferon-beta treatment of progressive disseminated sclerosis. Is it possibly without effect?].
    Foldspang A
    Ugeskr Laeger; 1999 Aug; 161(31):4418-21. PubMed ID: 10487112
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current therapy of multiple sclerosis].
    Vass K; Schmied M
    Wien Med Wochenschr; 1996; 146(19-20):514-9. PubMed ID: 9082651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Beta-interferon and multiple sclerosis].
    Clanet M
    Rev Neurol (Paris); 1993; 149(8-9):443-4. PubMed ID: 8009140
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interferon-beta in the treatment of multiple sclerosis].
    Panelius M; Salonen R; Ruutiainen J
    Duodecim; 1995; 111(7):587-9. PubMed ID: 8681813
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis].
    de Haan RJ; Polman CH
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2168-71. PubMed ID: 8984352
    [No Abstract]   [Full Text] [Related]  

  • 29. Interferon beta in the treatment of multiple sclerosis--closing remarks.
    Kappos L
    Mult Scler; 1995; 1 Suppl 1():S64-6. PubMed ID: 9345403
    [No Abstract]   [Full Text] [Related]  

  • 30. Interferon beta in multiple sclerosis. Relapses deserve treatment.
    Cardy P
    BMJ; 1997 Feb; 314(7080):602. PubMed ID: 9055732
    [No Abstract]   [Full Text] [Related]  

  • 31. Provision of treatment for multiple sclerosis.
    Compston A
    Lancet; 1999 May; 353(9165):1710-1. PubMed ID: 10335817
    [No Abstract]   [Full Text] [Related]  

  • 32. [10 years of interferon treatment in multiple sclerosis. Does the future belong to high-dose therapy?].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579501
    [No Abstract]   [Full Text] [Related]  

  • 33. Interferon beta: the current position.
    Boothman BR
    Br J Hosp Med; 1997 Mar 19-Apr 1; 57(6):277-80. PubMed ID: 9196574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interferon-beta-1b treatment of disseminated sclerosis].
    Sørensen S
    Ugeskr Laeger; 1997 Feb; 159(6):779-84. PubMed ID: 9045474
    [No Abstract]   [Full Text] [Related]  

  • 35. Needed in MS: evidence, not EVIDENCE.
    Kieburtz K; McDermott M
    Neurology; 2002 Nov; 59(10):1482-3. PubMed ID: 12451186
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon beta treatment for multiple sclerosis.
    Forbes RB; Swingler RJ
    Lancet; 1999 Feb; 353(9151):496-8. PubMed ID: 9989743
    [No Abstract]   [Full Text] [Related]  

  • 37. Preventing multiple sclerosis?
    Ebers GC
    Lancet; 2001 May; 357(9268):1547. PubMed ID: 11377638
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferon beta in multiple sclerosis. Current policy is sensible.
    Price C
    BMJ; 1997 Feb; 314(7080):600-1. PubMed ID: 9055728
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of disseminated sclerosis with beta-inferferon--why and why not?].
    Sørensen PS; De Neergaard L
    Ugeskr Laeger; 1999 May; 161(19):2790. PubMed ID: 10412314
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interferon beta-1b now also for the secondary progressive form of multiple sclerosis?].
    de Haan RJ; Vermeulen M
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):709-11. PubMed ID: 10347623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.